FINWIRES · TerminalLIVE
FINWIRES

$MLYS

4 stories mentioning MLYSUpdated 40d ago

Every FINWIRES story that references MLYS, newest first.

Insider Trading

Mineralys Therapeutics Insider Sold Shares Worth $2,696,322, According to a Recent SEC Filing

Eric Warren, Chief Commercial Officer, on June 26, 2026, sold 104,124 shares in Mineralys Therapeutics (MLYS) for $2,696,322. Following the Form 4 filing with the SEC, Warren has control over a total of 38,400 common shares of the company, with 38,400 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1933414/000193341426000095/xslF345X05/wk-form4_1782859276.xml

$MLYS
Insider Trading

Mineralys Therapeutics Insider Sold Shares Worth $1,960,601, According to a Recent SEC Filing

Jon Congleton, Director, Chief Executive Officer, on June 30, 2026, sold 75,000 shares in Mineralys Therapeutics (MLYS) for $1,960,601. Following the Form 4 filing with the SEC, Congleton has control over a total of 614,321 common shares of the company, with 614,321 shares held directly.SEC Filing:c

$MLYS
Insider Trading

Mineralys Therapeutics Insider Sold Shares Worth $652,638, According to a Recent SEC Filing

David Malcom Rodman, Chief Medical Officer, on May 11, 2026, sold 22,575 shares in Mineralys Therapeutics (MLYS) for $652,638. Following the Form 4 filing with the SEC, Rodman has control over a total of 63,443 common shares of the company, with 63,443 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1933414/000167265926000027/xslF345X05/wk-form4_1778722925.xml

$MLYS
Research

TD Cowen Initiates Mineralys Therapeutics at Buy

Mineralys Therapeutics (MLYS) has an average rating of buy and mean price target of $49.38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$MLYS

Track with the FINWIRES app suite

FolioX
FolioX
Track MLYS in your portfolio
WheelAI
WheelAI
Analyze MLYS options with the wheel strategy
StockInsider
StockInsider
See market sentiment on MLYS